Soumen Bhattacharyya: Hyperhomocysteinemia and Thrombosis – What Clinicians Should Know
Soumen Bhattacharyya, College Teacher in the Department of Physiology at RBC College for Women, shared a post on LinkedIn:
“Hyperhomocysteinemia and Thrombosis – What Clinicians Should Know
Hyperhomocysteinemia continues to sit in that interesting grey zone between biochemical abnormality and clinical significance.
What’s happening?
Elevated homocysteine levels can:
- Damage vascular endothelium
- Increase oxidative stress
- Promote a pro-thrombotic state
Clinical relevance:
Strongly associated with thrombosis in severe elevations (e.g., genetic disorders)
In mild-to-moderate cases, the evidence is inconsistent and debated
Treatment paradox:
While folate, Vitamin B12, and B6 effectively reduce homocysteine levels…
This doesn’t consistently translate into reduced thrombotic events.
Takeaway for practice:
Hyperhomocysteinemia is best viewed as a modifiable risk marker rather than a standalone cause of thrombosis.
It reminds us of a broader principle in medicine:
Not everything we can measure needs to be aggressively treated in isolation.
Curious to hear from fellow clinicians – Do you routinely screen for homocysteine in thrombotic workups?”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause